Hydroxycarbamide treatment reduces transcranial Doppler velocity in the absence of transfusion support in children with sickle cell anaemia, elevated transcranial Doppler velocity, and cerebral vasculopathy: the EXTEND trial.

Hydroxycarbamide treatment reduces transcranial Doppler velocity in the absence of transfusion support in children with sickle cell anaemia, elevated transcranial Doppler velocity, and cerebral vasculopathy: the EXTEND trial. Br J Haematol. 2021 11; 195(4):612-620.

View in: PubMed

subject areas

Adolescent
Anemia, Sickle Cell
Antisickling Agents
Blood Flow Velocity
Cerebrovascular Circulation
Cerebrovascular Disorders
Child
Child, Preschool
Female
Humans
Hydroxyurea
Incidence
Jamaica
Magnetic Resonance Imaging
Male
Neuroimaging
Prospective Studies
Recurrence
Single-Blind Method
Stroke
Ultrasonography, Doppler, Transcranial

authors with profiles

Robert J. Adams